# Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy

> **NCT06393309** · — · COMPLETED · sponsor: **Mazandaran University of Medical Sciences** · enrollment: 169 (actual)

## Conditions studied

- Treatment of Idiopathic Generalized Epilepsy

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Sodium valproate

## Key facts

- **NCT ID:** NCT06393309
- **Lead sponsor:** Mazandaran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-03
- **Primary completion:** 2024-03-19
- **Final completion:** 2024-03-19
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2024-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06393309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06393309, "Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06393309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*